Utilidad de la citometría de flujo en la determinación de microagregados plaquetarios en pacientes con stent tratados con clopidogrel

Revista del Laboratorio Clínico - Tập 1 - Trang 42-47 - 2008
Marcial Martínez Silvestre1, Eva Romero Sánchez1, Francisca Peñarrocha García1, Homero Beltrán Herrera1, Ignacio Sánchez Lázaro2, Antonio Salvador Sanz2
1Servicio de Análisis Clínicos. Hospital Universitario La Fe. Valencia. España
2Servicio de Cardiología, Hospital Universitario La Fe, Valencia, España

Tài liệu tham khảo

Wenaweser, 2005, Stent thrombosis is associated with an impaired response to antiplatelet therapy, J Am Coll Cardiol, 45, 1748, 10.1016/j.jacc.2005.01.058 Mehta, 2001, Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study, Lancet, 358, 527, 10.1016/S0140-6736(01)05701-4 Ajzenberg, 2005, Enhanced shear-induced platelet aggregation in patients who experience subacute stent thrombosis: a case-control study, J Am Coll Cardiol, 45, 1753, 10.1016/j.jacc.2004.10.079 Balaguer-Malfagon, 2006, Stent thrombosis in the modern era: Incidence, outcome and predictive factors, Rev Esp Cardiol, 59, 842, 10.1157/13091890 Barsky, 2006, Clopidogrel resistance: myth or reality?, J Cardiovasc Pharmacol Ther, 11, 47, 10.1177/107424840601100104 Wang, 2006, Aspirin and clopidogrel resistance: an emerging clinical entity, Eur Heart J, 27, 647, 10.1093/eurheartj/ehi684 Müller, 2003, Prevalence of clopidogrel non-responder among patients with stable angina pectoris scheduled for elective coronary stent placement, Thromb Haemost, 89, 783, 10.1055/s-0037-1613462 Gurbel, 2003, Clopidogrel for coronary stenting: response variability drug resistance, and the effect of pretreatment platelet reactivity, Circulation, 107, 2908, 10.1161/01.CIR.0000072771.11429.83 Jaremo, 2002, Individual variations of platelet inhibition after loading doses of clopidogrel, J Intern Med, 252, 233, 10.1046/j.1365-2796.2002.01027.x Serebruany, 2005, Variability in platelet responsiveness to clopidogrel among 544 individuals, J Am Coll Cardiol, 45, 246, 10.1016/j.jacc.2004.09.067 Gurbel, 2006, Drug insight: clopidogrel nonresponsiveness, Nat Clin Pract Cardiovasc Med, 3, 387, 10.1038/ncpcardio0602 Gurbel, 2005, Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study, J Am Coll Cardiol, 46, 1827, 10.1016/j.jacc.2005.07.056 Templin, 2006, Combined aspirin and clopidogrel resistance associated with recurrent coronary stent thrombosis, Clin Res Cardiol, 95, 122, 10.1007/s00392-006-0332-8 Geisler, 2006, Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation, Eur Heart J, 27, 2420, 10.1093/eurheartj/ehl275 Matsuno, 1999, Comparative antiplatelet effects of aspirin, vapiprost and GR144053, a GPIIb/IIIa antagonist, with a special reference to the role of platelet microaggregates, Br J Pharmacol, 127, 1129, 10.1038/sj.bjp.0702651 Miyamoto, 2003, Formation of platelet microaggregates correlates with adverse clinical outcome in patients with coronary artery disease, Thromb Haemost, 89, 681, 10.1055/s-0037-1613575 Steinhubl, 2002, Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial, JAMA, 288, 2411, 10.1001/jama.288.19.2411 Neubauer, 2003, Lipophilic statins interference with the inhibitory effects of clopidogrel on platelet function—a flow cytometry study, Eur Heart J, 24, 1744, 10.1016/S0195-668X(03)00442-1 Schmitz, 1998, European working group on Clinical Cell Analysis. Consensus protocol for the flow cytometric characterisation of platelet function, Thromb Haemost, 79, 885, 10.1055/s-0037-1615088 Matzdorff, 1998, Relative and absolute changes of activated platelets, microparticles and platelet aggregates after activation in vitro, Haemostasis, 28, 277 Yip, 2005, Serial changes in platelet activation in patients with unstable angina following coronary stenting: evaluation of the effects of clopidogrel loading dose in inhibiting platelet activation, Circ J, 69, 1208, 10.1253/circj.69.1208 Grossmann, 2004, Variable extent of clopidogrel responsiveness in patients after coronary stenting, Thromb Haemost, 92, 1201, 10.1160/TH04-01-0049 Samara, 2005, The difference between clopidogrel responsiveness and post-treatment platelet reactivity, Thromb Res, 115, 89, 10.1016/j.thromres.2004.07.002 Alstrom, 2007, The platelet inhibiting effect of a clopidogrel bolus dose in patients on long-term acetylsalicylic acid treatment, Thromb Res, 120, 353, 10.1016/j.thromres.2006.10.009 Von Beckerath, 2005, Absorption, metabolization, and antiplatelet effects of 300, -600-, and 900-mg loading doses of clopidogrel. Results of the ISAR-CHOICE (Intracoronary stenting antithrombotic regimen: choose between 3 high oral doses for immediate clopidogrel effect) Trial, Circulation, 112, 2946, 10.1161/CIRCULATIONAHA.105.559088 Angiolillo, 2006, Contribution of gene sequence variations of hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel, Arterioscler Thromb Vasc Biol, 26, 1681, 10.1161/01.ATV.0000223867.25324.1a Hetherington, 2005, Dimorphism in the P2Y1 ADP receptor gene is associated with increased platelet activation response to ADP, Arterioscler Thromb Vasc Biol, 25, 252, 10.1161/01.ATV.0000148708.44691.27 Geisler, 2006, Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation, Eur Heart J, 27, 2420, 10.1093/eurheartj/ehl275